Comment
doi: 10.1080/15265160902939933.
Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
Affiliations
- PMID: 19998162
- DOI: 10.1080/15265160902939933
Item in Clipboard
Comment
Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
Am J Bioeth.
2009 Aug.
No abstract available
Comment on
-
The duty to disclose adverse clinical trial results.Am J Bioeth. 2009 Aug;9(8):24-32. doi: 10.1080/15265160902984988. Am J Bioeth. 2009. PMID: 19998154
Similar articles
-
Disclosing clinical trial results: publicity, significance and independence.Am J Bioeth. 2009 Aug;9(8):W3-5. doi: 10.1080/15265160903088151. Am J Bioeth. 2009. PMID: 19998144 No abstract available.
-
Respecting participant autonomy and the disclosure of clinical trial results.Am J Bioeth. 2009 Aug;9(8):38. doi: 10.1080/15265160902979806. Am J Bioeth. 2009. PMID: 19998158 No abstract available.
-
The duty to disclose (even more) adverse clinical trial results.Am J Bioeth. 2009 Aug;9(8):33-4. doi: 10.1080/15265160902893874. Am J Bioeth. 2009. PMID: 19998155 No abstract available.
-
Ethical considerations.Epilepsy Res Suppl. 1993;10:137-48. Epilepsy Res Suppl. 1993. PMID: 8251089 Review. No abstract available.
-
The case of Chester M. Southam: research ethics and the limits of professional responsibility.Pharos Alpha Omega Alpha Honor Med Soc. 2002 Spring;65(2):4-9. Pharos Alpha Omega Alpha Honor Med Soc. 2002. PMID: 12099116 Review. No abstract available.
Cited by
-
Competing for patients: an ethical framework for recruiting patients with brain tumors into clinical trials.J Neurooncol. 2011 Sep;104(3):623-7. doi: 10.1007/s11060-011-0536-2. Epub 2011 Feb 12. J Neurooncol. 2011. PMID: 21318320
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical